Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
Conditions
- Contiguous Stage II Mantle Cell Lymphoma
- Noncontiguous Stage II Mantle Cell Lymphoma
- Recurrent Mantle Cell Lymphoma
- Stage I Mantle Cell Lymphoma
- Stage III Mantle Cell Lymphoma
- Stage IV Mantle Cell Lymphoma
Interventions
- DRUG: bortezomib
- BIOLOGICAL: rituximab
- OTHER: laboratory biomarker analysis
- OTHER: immunohistochemistry staining method
- GENETIC: RNA analysis
- GENETIC: gene expression analysis
- GENETIC: DNA analysis
- OTHER: pharmacological study
- OTHER: pharmacogenomic studies
- OTHER: Questionnaire Administration
Sponsor
City of Hope Medical Center
Collaborators